Amerisource Health Services LLC recalls Carbamazepine Extended-Release Tablets
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Failed Dissolution Specifications.
- Products
-
- Carbamazepine Extended-Release Tablets
- Where it was sold
-
Nationwide in the USA.
Nationwide
- Units affected
- 360 cartons
- About this recall
- Carbamazepine Extended-Release Tablets, USP 400 mg, 30 Tablets per carton (3x10 unit dose cards), Rx Only, American Health Packaging, Columbus, OH 43217. Carton NDC 60687-594-21; (Individual Dose NDC: 60687-594-11)